Literature DB >> 20022384

Principal domains of behavioral psychopathology identified by the Bipolar Inventory of Signs and Symptoms Scale (BISS).

Peter M Thompson1, Jodi M Gonzalez, Vivek Singh, John D Schoolfield, Martin M Katz, Charles L Bowden.   

Abstract

Current symptom rating scales and diagnostic categories for bipolar disorder (BD) do not provide dimensional profiles of the types of behavior disturbed in this complex disorder. To overcome these limitations we identified the principal domains of behavioral symptomatology in bipolar individuals, including all mood states, and used a more comprehensive rating scale for BD: the Bipolar Inventory of Signs and Symptoms Scale (BISS). A total of 246 patients with BD (196 with BD type I, and 50 with BD type II) were interviewed using the BISS. Exploratory factor analysis was performed on the BISS results using the maximum likelihood factor extraction method, followed by oblique rotation of the extracted factor loadings. We determined the strength of relationships between factor scores using the Pearson correlation coefficient. The following five factors were extracted: mania, depression, irritability, anxiety and psychosis. Anxiety was significantly correlated with depression and irritability. The mania factor score was only weakly associated with the other four factors. The domains of the BISS capture both the historical categories of depression and mania, plus irritability, psychosis, and an additional principal domain, anxiety. Despite the common occurrence of anxiety in BD, it has not been identified in most prior factor analyses, in part due to limited coverage of anxiety symptoms in the source scales. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20022384     DOI: 10.1016/j.psychres.2009.04.017

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  12 in total

1.  Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.

Authors:  William V Bobo; Noreen A Reilly-Harrington; Terence A Ketter; Benjamin D Brody; Gustavo Kinrys; David E Kemp; Richard C Shelton; Susan L McElroy; Louisa G Sylvia; James H Kocsis; Melvin G McInnis; Edward S Friedman; Vivek Singh; Mauricio Tohen; Charles L Bowden; Thilo Deckersbach; Joseph R Calabrese; Michael E Thase; Andrew A Nierenberg; Dustin J Rabideau; David A Schoenfeld; Stephen V Faraone; Masoud Kamali
Journal:  J Affect Disord       Date:  2014-03-13       Impact factor: 4.839

2.  SNAP-25a/b Isoform Levels in Human Brain Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex.

Authors:  Peter M Thompson; Dianne A Cruz; Elizabeth A Fucich; Dianna Y Olukotun; Masami Takahashi; Makoto Itakura
Journal:  Mol Neuropsychiatry       Date:  2015-12-01

3.  Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study.

Authors:  William V Bobo; Noreen A Reilly-Harrington; Terence A Ketter; Benjamin D Brody; Gustavo Kinrys; David E Kemp; Richard C Shelton; Susan L McElroy; Louisa G Sylvia; James H Kocsis; Melvin G McInnis; Edward S Friedman; Vivek Singh; Mauricio Tohen; Charles L Bowden; Thilo Deckersbach; Joseph R Calabrese; Michael E Thase; Andrew A Nierenberg; Dustin J Rabideau; David A Schoenfeld; Stephen V Faraone; Masoud Kamali
Journal:  J Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.153

4.  One-year treatment outcomes of African-American and Hispanic patients with bipolar I or II disorder in STEP-BD.

Authors:  Jodi M Gonzalez; Charles L Bowden; Nancy Berman; Ellen Frank; Mark S Bauer; Jane N Kogan; Margarita Alegría; David J Miklowitz
Journal:  Psychiatr Serv       Date:  2010-02       Impact factor: 3.084

5.  Manic symptom severity correlates with COMT activity in the striatum: A post-mortem study.

Authors:  Marco Bortolato; Consuelo Walss-Bass; Peter M Thompson; Jackob Moskovitz
Journal:  World J Biol Psychiatry       Date:  2016-07-26       Impact factor: 4.132

Review 6.  Bipolar pathophysiology and development of improved treatments.

Authors:  Charles L Bowden
Journal:  Brain Res       Date:  2008-06-11       Impact factor: 3.252

7.  Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.

Authors:  Andrew A Nierenberg; Louisa G Sylvia; Andrew C Leon; Noreen A Reilly-Harrington; Leah W Shesler; Susan L McElroy; Edward S Friedman; Michael E Thase; Richard C Shelton; Charles L Bowden; Mauricio Tohen; Vivek Singh; Thilo Deckersbach; Terence A Ketter; James H Kocsis; Melvin G McInnis; David Schoenfeld; William V Bobo; Joseph R Calabrese
Journal:  Clin Trials       Date:  2013-12-17       Impact factor: 2.486

8.  Differential neuregulin 1 cleavage in the prefrontal cortex and hippocampus in schizophrenia and bipolar disorder: preliminary findings.

Authors:  Ketan Marballi; Dianne Cruz; Peter Thompson; Consuelo Walss-Bass
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

9.  Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder.

Authors:  Charles L Bowden; Richard Priesmeyer; Mauricio Tohen; Vivek Singh; Joseph R Calabrese; Terry Ketter; Andrew Nierenberg; Michael E Thase; Gregg Siegel; Leslie H Siegel; Jim Mintz; Rif S El-Mallakh; Susan L McElroy; Melissa Martinez
Journal:  Psychopharmacol Bull       Date:  2021-03-16

10.  Concordance of psychiatric symptom ratings between a subject and informant, relevancy to post-mortem research.

Authors:  P M Thompson; C G Bernardo; D A Cruz; N S Ketchum; J E Michalek
Journal:  Transl Psychiatry       Date:  2013-01-15       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.